NIH-funded research R01 grant

Investigating how Protein Kinase D1 influences the transition from acute to chronic pancreatitis

Official title: Protein Kinase D1 as a switch from acute to chronic pancreatitis

Funded at Mayo Clinic Jacksonville · NIH-11046577 · Data updated 2026-11-12

This study is looking at how a protein called Protein Kinase D1 might influence the change from acute pancreatitis to a long-lasting condition, with the goal of finding new treatments that could help people with this illness.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville
NIH-funded
Lab location1 site (Jacksonville, United States)
Project startApril 1, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$340,388
NIH project number5R01DK139604-02
Project IDNIH-11046577 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced acute pancreatitis and are at risk of developing chronic pancreatitis.

Less likely to help

Patients with chronic pancreatitis that has already progressed significantly may not benefit from this research.

What this research studies

This research explores the role of Protein Kinase D1 in the progression of acute pancreatitis to a chronic condition. It aims to understand how this protein affects acinar cells in the pancreas, potentially leading to chronic inflammation and fibrosis. The study will utilize animal models to observe the effects of PKD1 on the development and resolution of chronic pancreatitis. By identifying the molecular mechanisms involved, the research seeks to develop targeted therapies that could inhibit PKD1 and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent acute pancreatitis from becoming chronic, reducing the risk of complications such as pancreatic cancer.

How similar studies have gone: While the specific approach of targeting Protein Kinase D1 is novel, similar research has shown promise in understanding the mechanisms of pancreatitis progression.

Where this research is happening

  • Mayo Clinic Jacksonville
    Jacksonville, United States
    Active

Researchers

  • Principal investigator: Storz, Peter — Mayo Clinic Jacksonville
  • Study coordinator: Storz, Peter

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.